BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33675069)

  • 1. Indocyanine green guidance improves the efficiency of extended pelvic lymph node dissection during laparoscopic radical prostatectomy.
    Claps F; Ramírez-Backhaus M; Mir Maresma MC; Gómez-Ferrer Á; Mascarós JM; Marenco J; Collado Serra A; Casanova Ramón-Borja J; Calatrava Fons A; Trombetta C; Rubio-Briones J
    Int J Urol; 2021 May; 28(5):566-572. PubMed ID: 33675069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of indocyanine green-guided extended pelvic lymph node dissection during robot-assisted radical prostatectomy.
    Shimbo M; Endo F; Matsushita K; Hattori K
    Int J Urol; 2020 Oct; 27(10):845-850. PubMed ID: 32634854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indocyanine Green Guided Pelvic Lymph Node Dissection: An Efficient Technique to Classify the Lymph Node Status of Patients with Prostate Cancer Who Underwent Radical Prostatectomy.
    Ramírez-Backhaus M; Mira Moreno A; Gómez Ferrer A; Calatrava Fons A; Casanova J; Solsona Narbón E; Ortiz Rodríguez IM; Rubio Briones J
    J Urol; 2016 Nov; 196(5):1429-1435. PubMed ID: 27235788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging.
    Jeschke S; Lusuardi L; Myatt A; Hruby S; Pirich C; Janetschek G
    Urology; 2012 Nov; 80(5):1080-6. PubMed ID: 22990053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence Guided Targeted Pelvic Lymph Node Dissection for Intermediate and High Risk Prostate Cancer.
    Hruby S; Englberger C; Lusuardi L; Schätz T; Kunit T; Abdel-Aal AM; Hager M; Janetschek G
    J Urol; 2015 Aug; 194(2):357-63. PubMed ID: 25896557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
    BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence-supported lymphography and extended pelvic lymph node dissection in robot-assisted radical prostatectomy: a prospective, randomized trial.
    Harke NN; Godes M; Wagner C; Addali M; Fangmeyer B; Urbanova K; Hadaschik B; Witt JH
    World J Urol; 2018 Nov; 36(11):1817-1823. PubMed ID: 29767326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free-indocyanine green-guided pelvic lymph node dissection during radical prostatectomy.
    Claps F; de Pablos-Rodríguez P; Gómez-Ferrer Á; Mascarós JM; Marenco J; Collado Serra A; Casanova Ramón-Borja J; Calatrava Fons A; Trombetta C; Rubio-Briones J; Ramírez-Backhaus M
    Urol Oncol; 2022 Nov; 40(11):489.e19-489.e26. PubMed ID: 36175317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study.
    Preisser F; van den Bergh RCN; Gandaglia G; Ost P; Surcel CI; Sooriakumaran P; Montorsi F; Graefen M; van der Poel H; de la Taille A; Briganti A; Salomon L; Ploussard G; Tilki D;
    J Urol; 2020 Feb; 203(2):338-343. PubMed ID: 31437119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of limited and extended pelvic lymph node dissection during robot-assisted radical prostatectomy for patients with localized prostate cancer: A retrospective, propensity score matching analysis.
    Hori S; Nakai Y; Tachibana A; Omori C; Nishimura N; Inoue K; Tomizawa M; Shimizu T; Morizawa Y; Gotoh D; Miyake M; Torimoto K; Yoneda T; Fujimoto K; Tanaka N
    Int J Urol; 2023 Feb; 30(2):168-175. PubMed ID: 36305671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Adding Sentinel Node Biopsy to Extended Pelvic Lymph Node Dissection on Biochemical Recurrence in Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy.
    Grivas N; Wit EMK; Kuusk T; KleinJan GH; Donswijk ML; van Leeuwen FWB; van der Poel HG
    J Nucl Med; 2018 Feb; 59(2):204-209. PubMed ID: 28747519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Specific Mapping Study Using Fluorescence Sentinel Lymph Node Detection in Patients with Intermediate- and High-risk Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection.
    Nguyen DP; Huber PM; Metzger TA; Genitsch V; Schudel HH; Thalmann GN
    Eur Urol; 2016 Nov; 70(5):734-737. PubMed ID: 26856960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does pelvic lymph node dissection improve the biochemical relapse-free survival in low-risk prostate cancer patients treated by laparoscopic radical prostatectomy?
    Daimon T; Miyajima A; Maeda T; Hattori S; Yasumizu Y; Hasegawa M; Kosaka T; Kikuchi E; Nakagawa K; Oya M
    J Endourol; 2012 Sep; 26(9):1199-202. PubMed ID: 22524402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer?
    Mitsuzuka K; Koie T; Narita S; Kaiho Y; Yoneyama T; Kawamura S; Tochigi T; Ohyama C; Habuchi T; Arai Y
    Int J Urol; 2013 Nov; 20(11):1092-6. PubMed ID: 23387553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy.
    von Bodman C; Godoy G; Chade DC; Cronin A; Tafe LJ; Fine SW; Laudone V; Scardino PT; Eastham JA
    J Urol; 2010 Jul; 184(1):143-8. PubMed ID: 20478587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis.
    Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH
    BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative Fluorescence Imaging for Detection of Sentinel Lymph Nodes and Lymphatic Vessels during Open Prostatectomy using Indocyanine Green.
    Yuen K; Miura T; Sakai I; Kiyosue A; Yamashita M
    J Urol; 2015 Aug; 194(2):371-7. PubMed ID: 25584996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional database.
    Schiavina R; Bianchi L; Borghesi M; Briganti A; Brunocilla E; Carini M; Terrone C; Mottrie A; Dente D; Gacci M; Gontero P; Gurioli A; Imbimbo C; La Manna G; Marchioro G; Milanese G; Mirone V; Montorsi F; Morgia G; Munegato S; Novara G; Panarello D; Porreca A; Russo GI; Serni S; Simonato A; Urzì D; Verze P; Volpe A; Martorana G
    Int J Urol; 2016 Dec; 23(12):1000-1008. PubMed ID: 27620370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes.
    Ledezma RA; Negron E; Razmaria AA; Dangle P; Eggener SE; Shalhav AL; Zagaja GP
    World J Urol; 2015 Nov; 33(11):1689-94. PubMed ID: 25701128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended robot-assisted laparoscopic prostatectomy and extended pelvic lymph node dissection as a monotherapy in patients with very high-risk prostate cancer Patients.
    Miura N; Sugihara N; Funaki K; Kakuda T; Koyama K; Watanabe R; Sawada Y; Noda T; Nishimura K; Fukumoto T; Miyauchi Y; Kikugawa T; Saika T
    Cancer Med; 2021 Nov; 10(22):7968-7976. PubMed ID: 34562303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.